Blueberry for Health & Longevity - Quick Reference Sheet

Blueberry for Health & Longevity

Created on 09/02/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A cup of blueberries daily improves how well arteries widen; half a cup does nothing. Memory gains appear only in adults already declining. Blood pressure, blood fat and blood sugar findings disagree. The clearest harm is reduced plant-source iron uptake alongside berries — timing, not amount. (Full Review)

Protocol

Standard daily amount
One cup (150 g)
Fresh or frozen fruit, about 300 mg anthocyanins, or 22–26 g freeze-dried powder.
Sub-threshold amounts do not work
Half a cup: no effect
No measurable change on any endpoint over six months; below 75 g daily is untested.
Single versus split dose
Two doses, morning and evening
One trial split the powder across the morning and evening meals; splitting matches the two-phase artery response.
Time to effect
Artery dilation
1–2 hours
Acute widening after a single serving; second rise near six hours.
Cognition
12–26 weeks
Concentrated in adults with existing decline.
Blood pressure & metabolism
12–26 weeks
Ambulatory pressure and metabolic markers moved.

Benefits

Contraindications
  • Confirmed immunoglobulin E-mediated blueberry allergy
Key Interactions
  • Oral iron salts (ferrous sulfate, gluconate)
  • Iron-containing multivitamins and iron tablets
  • Iron, zinc and non-heme mineral supplements
  • Antacids and proton pump inhibitors (omeprazole)
  • Vitamin K antagonists (warfarin, acenocoumarol)
  • Antihypertensives (amlodipine, lisinopril)
  • Glucose-lowering agents (metformin, insulin)
  • Additive supplements (nitrate, cocoa flavanols)
  • Other interventions (low-FODMAP, ketogenic diets)

Risk & Side Effects

  • High:
  • Medium: Reduced Non-Heme Iron Absorption
  • Low: Gastrointestinal Discomfort at High Intakes; Allergic Reactions Including Anaphylaxis; Carbohydrate Load in Carbohydrate-Restricted Protocols
  • Speculative: Pesticide Residue Exposure; Interference with Drug Metabolism; Oxalate Contribution to Stone Formation

Monitoring

Marker Target Why
Blood pressure (home or 24-hour average) Below 120/75 mmHg Vascular endpoint that moved in trials
Ferritin 50–125 ng/mL; 40–100 menstruating women Detects iron depletion
Glycated hemoglobin 4.8–5.4% Moved in one diabetes trial, not in pooled analyses
Fasting insulin 2–6 µIU/mL Longest trial's primary endpoint; unchanged
High-density lipoprotein cholesterol Above 55 mg/dL men, 65 mg/dL women Rose in statin non-users
High-sensitivity C-reactive protein Below 0.5 mg/L Inflammation predicted cognitive response
Flow-mediated dilation No consumer target exists; track change from own baseline Moved most consistently across trials

Cadence: Baseline panel; blood pressure at 4 weeks; full panel at 12 weeks; then every 6–12 months, ferritin annually or sooner if menstruating.

Qualitative Assessment

  • Word-finding fluency and name recall in conversation
  • Speed of response in a familiar cognitively demanding task
  • Bloating, stool form and frequency against the pre-start diary
  • Perceived exertion at a fixed submaximal effort
  • Energy stability across the two hours after a carbohydrate-containing meal